Q2 Review: After Weak Q2, Can Biocon Bounce Back In Q3? | BQPrime

NDTV Profit

Published On

15 Nov 2022, 01:26 PM IST

Last Updated On

15 Nov 2022, 02:32 PM IST

#Q2WithBQ | Biocon's second-quarter profit falls due to a tax write-off; margins come under pressure as well. MD & CEO Siddharth Mittal shares growth strategy and plans for FY23. #BQLive

Add us to your Preferences

Set as your preferred source on Google

RECOMMENDED FOR YOU

'Moral Policing' Dressed Up As Policy: Anupam Mittal Takes Dig At Gaming Bill

timelogo

Dealing Room Buzz: Biocon, Cipla, Himadri Speciality, Apollo Hospital, Suzlon, M&M, Kaynes Tech

timelogo

LTIMindtree Q1 Review: Here's What Held Back Analysts Ratings Upgrade Despite Earnings Beat

timelogo

Biocon Aims To Lead Copycat Wegovy Sales In Canada From Next Year

timelogo